| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |